Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Pharmacol Ther. Sep 5, 2022; 13(5): 77-87
Published online Sep 5, 2022. doi: 10.4292/wjgpt.v13.i5.77
Table 1 Patient demographics
All (N = 154)
PEG ≤ 7 d (N = 62, 40.26%)
PEG > 7 d (N = 92, 59.74%)
P value
N
SD
N
SD
N
SD
Age69.6215.0274.6513.8966.2414.870.00051
Sex0.0658
Female7850.653759.684144.57
Male7649.352540.325155.43
Any comorbidity14795.455995.168895.651.00002
Number of comorbidities 0.43393
074.5534.8444.35
12616.881219.351415.22
23724.031320.972426.09
34126.621727.422426.09
42616.881219.351415.22
585.1946.4544.35
653.2500.0055.43
731.9511.6122.17
800.0000.0000.00
910.6500.0011.09
Table 2 Patient comorbidities
Types of comorbidities All (N = 154)
PEG ≤ 7 d (N = 62, 40.26%)
PEG > 7 d (N = 92, 59.74%)
P value
N
%
N
%
N
%
Acute respiratory distress syndrome10.6500.0011.091.00001
Acute kidney injury21.3000.0022.170.5158
Alcohol abuse53.2523.2333.261.00001
Amyotrophic lateral sclerosis10.6500.0011.091.00001
Anemia42.6023.2322.171.00001
Aortic dissection10.6500.0011.091.00001
Aortic stenosis10.6500.0011.091.00001
Arrhythmias74.5546.4533.260.44031
Atrial fibrillation3220.781727.421516.300.0955
Breast cancer31.9523.2311.090.56521
Coronary artery disease2918.83914.522021.740.2609
Cirrhosis10.6511.6100.000.40261
Chronic kidney disease149.0923.231213.040.0377
Colon cancer21.3023.2300.000.16051
Chronic obstructive pulmonary disease95.8411.6188.700.08531
Dementia159.7458.061010.870.5648
Diabetes mellitus5233.771930.653335.870.5014
Deep vein thrombosis10.6511.6100.000.40261
Heart failure2415.581117.741314.130.5445
Hyperlipidemia4529.222032.262527.170.4963
Hypertension12178.574572.587682.610.1369
Lung cancer10.6500.0011.091.00001
Nonalcoholic steatohepatitis10.6500.0011.091.00001
Obstructive sleep apnea31.9511.6122.171.00001
Peripheral artery disease63.9058.0611.090.03911
Parkinson's disease21.3000.0022.170.51581
Patent Foramen Ovale10.6511.6100.000.40261
Prostate cancer21.3000.0022.170.51581
Pulmonary hypertension10.6511.6100.000.40261
Seizure disorder42.6023.2322.171.00001
Stroke3824.681422.582426.090.62061
Substance abuse10.6500.0011.091.00001
Thrombocytopenia21.3011.6111.091.00001
Thyroid cancer10.6511.6100.000.40261
Table 3 Mortality and complications in percutaneous endoscopic gastrostomy tubes placed ≤ 7 d vs > 7 d post stroke

Early PEG group (≤ 7 d)
Late PEG group (> 7 d)
Analysis value (P)
30-d mortality (Number of events)351.001
Peri-procedural complications (number of events)380.531
Post-procedural complications (number of events)20340.551
Hospital length of stay (d)12.922.34< 0.0012
Table 4 Types of peri-procedural and post procedural complications

Early PEG group
Late PEG group
Analysis value (P) Fisher’s exact
Peri procedural complication
Pulled PEG tube 011
Pulmonary edema011
NSTEMI011
Bleeding040.15
Pneumonia111
Evolving stroke/herniation100.4
Post procedural complications
Aspiration8140.69
Pneumonia10160.84
Bleeding221
Buried bumper100.4
Cardiac arrest210.57
Death780.59
Ileus011
Infection540.49
Necrotizing pancreatitis011
Pulled PEG tube390.36
Pulmonary embolism030.27
Respiratory failure130.65
Seroma100.4
Stroke121
Table 5 Predictors of mortality: Multivariate logistic regression analysis
Death in 30 d, OR [95%CI]Death in 90 d, OR [95%CI]Peri-procedural complication, OR [95%CI]Post-procedural complications, OR [95%CI]
Protein calorie malnutrition (albumin ≤ 3.2)0.757 [0.179-3.21]0.854 [0.289-2.527]1.31 [0.37-4.7]1.07 [0.54-2.11]
Documented SIRS criteria or infection pre-procedure0.524 [0.06-4.52]0.56 [0.12-2.67]1.55 [0.38-6.28]1.92 [0.85-4.35]
Presence of cardiovascular risk equivalent independent of this stroke0.24 [0.05-1.24]0.35 [0.11-1.09]0.65 [0.19-2.23]1.63 [0.82-3.24]